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ABSTRACT
Sickle cell disease encompasses a wide range of genotypic presentation with particular clinical features. The entity affects 
millions of people, particularly those whose ancestors came from sub-Saharan Africa and other countries in the Western 
Hemisphere, Saudi Arabia, and India. Currently, the high frequency of S and C genes reflects natural selection through 
the protection of heterozygotes against severe malaria, the high frequency of consanguineous marriages, improvement 
of some public health policies and the nutritional standards in the poorer countries where newborns are now living long 
enough to present for diagnosis and management. Although there is a high burden of the disease, in many countries, the 
new-born sickle cell screening test is being performed and is rendering an early diagnosis; however, it is still difficult for 
sickle cell patients to find proper treatment and adequate follow-up. Moreover, in many countries, patients are neither 
aware of their diagnosis nor the care they should receive to prevent complications; also, they do not receive adequate 
genetic counseling. Hemoglobin SC (HbSC) disease is the most frequent double sickle cell heterozygosis found in Brazil. 
The clinical course tends to be more benign with fewer hospitalizations compared with double homozygotic SS patients. 
However, HbSC patients may present severe complications with a fatal outcome. We report the case of a 36-year-old man 
who presented to the emergency care facility with symptoms consistent with the diagnosis of sickling crisis. The outcome 
was unfavorable and death occurred just hours after admission. The autopsy revealed a generalized vaso-occlusive crisis 
by sickled red cells, bone marrow necrosis, and fat embolism syndrome. 
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CASE REPORT
A 36-year-old mulatto male patient sought the 
emergency facility complaining of lumbar pain of 
progressive intensity over the past 3 days that worsened 
with trunk movement. This symptom irradiated to 
the dorsum and was accompanied by breathlessness. 
Concomitantly, he complained of wheezing, a cough 
with mucoid sputum, which was soon followed by dark 
urine. He had known diagnosis of SCD since the age of 
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23 years when he experienced an episode of priapism 
that required surgical intervention. Since then he had 
not followed any medical treatment. However, he 
experienced repeated episodes of bone pain, for which 
he used over-the-counter painkillers as self-medication. 
He ignored the same diagnosis among his relatives. 
He smoked for 2 years in his youth and still consumed 
alcoholic beverages. On physical examination, he was 
slightly pale, non-icteric and afebrile. His pulse rate was 
124 beats per minute, blood pressure 110/80 mmHg, 
respiratory rate 28 respiratory movements per minute 
(rmpm), and room air oximetry was 83%. His body 
mass index was 25. No edema or lymphadenopathy 
were found. The heart and lungs examination was 
unremarkable; however, the abdomen was diffusely 
tender and the liver was palpable 2 cm below the right 
costal margin. The examination of his back and lumbar 
region was normal. The laboratory work-up disclosed 
normocytic normochromic anemia with a hemoglobin 
of 10.9 g/dL (reference value [RV]: 12.3-15.3 g/dL); 
hematocrit of 30.1% (RV: 36-45%); red cell distribution 
width of 20.6% (RV: 14%); leukocytosis with the 
presence of myelocytes and metamyelocytes in 
the peripheral blood; and a normal platelet count. 
The peripheral blood film revealed the presence of 
poikilocytosis, target cells, and stomatocytes; rare 
erythrocytes showed the presence of Howell-Jolly bodies, 
20 polychromatic, 19 orthochromatic erythroblasts per 
100 leukocytes and occasional sickled erythrocytes. 
Reticulocyte count was not available. C-reactive protein 
was 173 mg/L (RV: <5 mg/L), lactate dehydrogenase 
686 U/L (RV: <250 U/L), and a total bilirubin 1.49 mg/dL 
(RV: <1.2 mg/dL) at the expense of indirect bilirubin. 
The renal function tests, electrolytes, liver enzymes, 
and urinalysis were normal. Blood and urine cultures 
were negative. The chest x-ray and computed 
tomography (CT) revealed peri-hilar bilateral confluent 
ground-glass opacities rendering small consolidations 
(Figures 1 and 2). An apparently calcified spleen of 
reduced dimension was an additional finding.
With the working diagnosis of hemolytic crisis, and 
a possible pulmonary infection, the patient was treated 
with saline, ceftriaxone, clarithromycin, morphine, 
and oxygen supplementation. His vital signs improved 
over the next 12 hours, but suddenly he presented 
Figure 1. Chest radiograph showing bilateral air space opacification and cardiac silhouette enlargement.
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Figure 2. Chest CT, pulmonary window, axial view in the upper (A), middle (B), and lower thirds (C) of the lungs and 
coronal reconstruction (D) showing multiple ground-glass opacities in all pulmonary lobes, tiny foci of consolidation 
associated with septal thickening mostly in the upper pulmonary fields.
worsened abdominal pain with nausea, vomiting and 
tachypnea (respiratory rate of 36 rmpm). He became 
obtunded and unresponsive to any stimuli, and 
presented cardiac arrest in pulseless electrical activity 
followed by asystole. Aspiration of vomiting was 
evident during the orotracheal intubation maneuver.
The capillary electrophoresis of the hemoglobin 
undertaken after death revealed the presence 
of 1.9% HbF, 50.3% HbS, 3.6% HbA2, and 44.2% HbC, 
rendering the diagnosis of hemoglobinopathy SC.
AUTOPSY FINDINGS
The lungs were edematous and boggy with multiple 
areas of friable consolidation and gross thromboemboli 
(Figure 3).
Microscopic examination showed acute and 
organizing thrombi, and mainly necrotic bone marrow 
embolism in pulmonary artery branches and arterioles, 
fat embolism in the alveolar septa capillary, and fibrin 
thrombi. There were multifocal areas of pulmonary 
congestion, hemorrhage, alveolar edema, and diffuse 
alveolar damage (Figure 4). Focal hemosiderin deposition 
was a sign of previous chronic hemorrhage.
The kidneys showed congestion, acute tubular 
necrosis, and glomerular fat emboli.
The bone marrow was hypercellular, mainly due 
to precursor erythroid cell hyperplasia, with large areas 
of infarction (about 50%), hemorrhage, and sickled 
cells (Figure 5).
The brain was mildly congested and edematous. 
Microscopically, it showed intraparenchymal vascular 
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Figure 3. Gross picture of formalin-fixed left lung showing areas of hemorrhage and thromboemboli (arrowheads).
Figure 4. Photomicrography of the lung. A – Organizing thrombus and diffuse congestion (H&E 12.5X); B – Fibrin 
microthrombus (right) and a fat droplet in a capillary vessel (left) (H&E 400X); C – Small fat droplets (arrowheads) 
(H&E 400X); D – Adipocytes in the capillaries of alveolar septa (H&E 400X).
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congestion and small foci of recent perivascular 
hemorrhage with sickled red cells and some pyknotic 
neurons.
The liver was congested and microscopically 
showed diffuse sinusoidal congestion with sickled 
red cells, mild steatosis, and foci of extramedullary 
hematopoiesis.
The spleen was diminished and atrophic, with 
fibrous plaques on the surface and extensive scarring 
fibrosis and calcifications in the parenchyma. Multiple 
Gamna-Gandy nodules with calcifications and 
hemosiderin deposits were seen.
Other findings were systemic congestion with 
sickled red cells, foci of ischemic necrosis in the 
pancreas, adrenals, and gastrointestinal tract. The heart 
showed moderate hypertrophy of the left ventricle 
wall.
The cause of the death was attributed to SCD 
crisis complicated by bone marrow necrosis and fat 
embolism syndrome with fatal impairment of lung 
function due to thrombosis, hemorrhage, and acute 
alveolar damage.
DISCUSSION
Hemoglobin SC disease (HbSC) is part of a 
group of disorders called “sickle cell diseases” 
(SCDs), which comprises hemoglobin SC disease 
and other hemoglobinopathies such as SD, SE, and 
others.1 These are hereditary hemoglobinopathies, 
which, in due course of genetic alterations, result in 
defective hemoglobin and consequent altered-form 
erythrocytes due to hemoglobin polymerization 
(which is the underlying mechanism for most of the 
complications of the disease).2 In 2001, newborn 
screening for SCD started in Brazil when the National 
Newborn Screening Program (PNTN)/Guthrie test 
was founded. According to data from the Ministry 
of Health, around 3500 children are born with SCD 
each year in Brazil, and the estimated number of cases 
of the disease ranges between 25,000 and 30,000, 
which shows the high prevalence of this disease in 
the Brazilian population, and its importance to public 
health.1 SCD is not only relevant in Brazil, but also in 
other parts of the world, where it is considered a public 
health concern, especially in Africa.3,4
Among all of SCD, SS, and SC genotypes are the most 
common.5 The SS genotype (inheritance of 2 βS alleles), 
also known as sickle cell anemia (SCA), is a debilitating 
disease with severe pain crisis, hemolysis, increased 
susceptibility to infections, cerebrovascular events, 
chronic organ damage, frequent hospitalizations, 
a n d  c o n s e q u e n t l y  l o w  e x p e c t a n c y  o f  l i f e 
(42 years for men and 48 years for women).6 Although 
SC hemoglobinopathy has a more protracted course, 
both SC and SS may present with similar complications.7 
Studies focused on laboratory biomarkers have 
shown that SCA individuals are more associated with 
endothelial dysfunction and hemolysis, while the HbSC 
genotype is more associated with increased blood 
viscosity and inflammatory disorders.8 Proliferating 
retinitis, osteonecrosis, and acute chest syndrome, may 
Figure 5. Photomicrography of the necrotic bone marrow (A) (H&E 400X) and branch of the pulmonary artery 
(B) showing embolization of necrotic bone marrow with interstitial adipocytes (H&E 100X).
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have equal or higher incidence in HbSC compared to 
SCA.9 The first manifestation of HbSC usually appears 
around 20 years of age and irreversible organ failure 
is 10-35 years later than SCA.10 Our patient first 
became aware he had SCD at the age of 23, when 
he experienced an episode of priapism. However, 
apparently, he was not well informed of the HbSC 
diagnosis, which was only confirmed post-mortem 
with the hemoglobin electrophoresis.
During the patient’s brief stay in the hospital, 
the working diagnosis was of SCD, and there was 
evidence suggesting both SCA and HbSC as possible 
causes. The radiological findings of an atrophic 
and calcified spleen suggested SCA. In SCA, most 
patients present with autoinfarction and asplenia 
within the first 18-36 months of life. Meanwhile, 
HbSC patients often have preserved splenic function 
(only 36% of HbSC patients have asplenic findings).9,11,12 
However, the laboratory findings with the hemoglobin 
of 10.9 g/dL and the hematocrit of 30.1% were 
more consistent with the diagnosis of HbSC or sickle 
cell trait.8
Our patient’s cause of death, depicted at autopsy, 
was necrosis of the bone marrow with subsequent fat 
embolism syndrome (FES) and sickled red cells in the 
pulmonary capillaries. This clinical entity is the result 
of the release of fat globules into the circulation, 
causing respiratory and neurologic damage, cutaneous 
and hematological manifestations.13 Although FES 
is most often associated with long bone fractures, 
occurring in up to 2.4% of multiple long bone fracture 
patients, it is a dreadful known complication of SC 
hemoglobinopathy.14
FES as a consequence of bone marrow necrosis 
in individuals with SCD was first described by Wade 
and Stevenson,15 in 1941, who found “widespread 
necrosis with marked reduction in the blood-forming 
constituents and fat, and fat emboli in the lung, liver, 
brain, spleen and kidneys.” In 2005, a review article16 
retrieved 24 cases in the literature. Nine years later, 
Tsitsikas et al.17 reported 58 gathered cases. Out of 
these 58 patients, 11 (19%) had HbSS, 25 (43%) 
presented HbSC and 10 (17%) had HbSβ+. The higher 
frequency of FES in HbSC individuals may be explained 
by higher hematocrit and subsequent higher blood 
viscosity, although the entire pathogenesis of FES is 
still not fully understood.18
Bone marrow necrosis is a common finding 
in SCD patients. Due to the anatomy of trabecular 
bone, the material from the necrotic marrow enters 
the venules, gaining access to the veins and the 
systemic circulation.16 It is important to understand 
the difference between bone marrow embolism and 
fat embolism. The former has been observed mainly in 
the medium and small branches of pulmonary arteries, 
while the latter ends up in the microscopic circulation.19
Although mechanical obstruction by the fat 
emboli is necessary for the occurrence of FES, it is not 
the only requirement. Pell et al.20 showed fat emboli 
passing through the heart (using transesophageal 
echocardiography) in cases of long bone fracture 
patients in a much higher frequency than FES occurs. 
Therefore, it has been hypothesized that biochemical 
factors, such as the agglutination of chylomicrons and 
very-low-density lipoprotein cholesterol and direct 
damage to the lung tissue by free fatty acids, play an 
important role in the pathogenesis of FES.21,22
There are still no definitive criteria for the 
diagnosis of FES, which is usually made on clinical 
grounds. However, biochemical and imaging tests 
may be ancillary tools. The classic triad is a red-brown 
petechial rash, mostly on the head, neck, anterior 
thorax, axillae, and sub-conjunctiva; central nervous 
system depression and pulmonary edema. Gurd’s23 
criteria is most commonly used for diagnosing FES, 
although its reliability has been questioned and other 
schemes have been proposed, such as Schonfeld’s and 
Lindeque et al.’s24 criteria. In the appropriate setting, 
the rash is very specific for FES. However, it is present 
in less than half the patients.25 Hypoxemia often occurs 
within the first 72 hours along with thrombocytopenia 
and leukocytosis.26
Chest radiography usually reveals unspecific 
diffuse or patchy bilateral opacities.23 In contrast, 
chest CT may be useful to evaluate the patients with 
the potential diagnosis of FES, and, more importantly, 
to rule out or demonstrate an alternative diagnosis. 
The most common finding on the CT is the patchy 
ground-glass opacities, which are usually associated 
with interlobular septal thickening (crazy-paving 
pattern), and eventually airspace consolidation and 
small centrilobular nodules.27
Bronchoalveolar lavage also has been described 
as an ancillary tool for the diagnosis of FES. Patients 
with FES may present fat-laden macrophages in a 
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percentage that ranges from 31% to 82%, while 
patients without FES present less than 2%. A cut-off 
value of 5% is apparently sensible for diagnosing FES, 
but with poor specificity. However, if the cut-off raises 
to 30% the specificity also raises substantially.28-32
The mortality of SC crisis with FES is high. In their 
2014 review, Tsitsikas et al.17 found 64% mortality. 
Comparing the patients of different groups that 
received exchange transfusion (ET), top-up transfusion, 
or no transfusion, the higher survival rate was observed 
in the ET group (mortality rate of 29%, 61%, and 
91%, respectively), indicating that ET may be the 
cornerstone in the treatment of FES. However, clinical 
trials are lacking to support such an observation. 
The mortality rate of SCD complicated by FES might 
be underestimated because many cases are only 
diagnosed postmortem; and diagnosis of milder cases 
is often difficult and missed.17
Our patient presented with abdominal and lumbar 
pain, hypoxemia, and bilateral lung opacities, and a 
history of sickle cell disease, which led to the diagnosis 
of vaso-occlusive crisis and acute chest syndrome 
(ACS). This clinical presentation fulfilled the criteria for 
ACS, since there was a new radiographic pulmonary 
infiltrate associated with hypoxemia, tachypnea, 
cough, and wheezing.33 Fat embolism is one of the 
proposed underlying mechanisms of ACS.34 Our patient 
had neither petechial rash nor central nervous system 
depression prior to his cardiac arrest. The diagnosis of 
FES was not made ante-mortem possibly because of 
the lack of its clinical hallmarks and its resemblance 
with ACS. The chest imaging also led to a diagnosis of 
a possible lung infection. Moreover, FES is a rare event 
in non-traumatic patients, whereas ACS is a frequent 
diagnosis in Brazilian emergency rooms.
We conclude that SCD patients who present 
with back and abdominal pain associated with 
respiratory failure and laboratory findings consistent 
with hemolysis (even in the absence of marked sickled 
erythrocytes) should ever be treated in intensive care 
units and those who rapidly progress to neurological 
dysfunction should early be submitted to ET.
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